scholarly journals A pilot randomized controlled trial to improve sleep and fatigue in children with central nervous system tumors hospitalized for high‐dose chemotherapy

2019 ◽  
Vol 66 (8) ◽  
Author(s):  
Valerie E. Rogers ◽  
Shijun Zhu ◽  
Sonia Ancoli‐Israel ◽  
Lianqi Liu ◽  
Belinda N. Mandrell ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Randomized Controlled Trial ◽  
Nervous System ◽  
Controlled Trial ◽  
High Dose Chemotherapy ◽  
Central Nervous System Tumors ◽  
High Dose ◽  
Nervous System Tumors ◽  
Randomized Controlled ◽  
Pilot Randomized Controlled Trial

Feasibility of metronomic maintenance chemotherapy following high-dose chemotherapy for malignant central nervous system tumors

2008 ◽  
Vol 50 (5) ◽  
pp. 970-975 ◽  
Author(s):  
L. Mi Rim Choi ◽  
Brian Rood ◽  
Naynesh Kamani ◽  
Deborah La Fond ◽  
Roger J. Packer ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
High Dose Chemotherapy ◽  
Central Nervous System Tumors ◽  
High Dose ◽  
Maintenance Chemotherapy ◽  
Nervous System Tumors

scholarly journals Switching Tenofovir/Emtricitabine/Efavirenz (TDF/FTC/EFV) to TDF/FTC/Rilpivirine vs Continuing TDF/FTC/EFV in HIV-Infected Patients With Virological Suppression: A Randomized Controlled Trial

2019 ◽  
Vol 6 (7) ◽  
Author(s):  
Sirichai Wiriyatanakorn ◽  
Somnuek Sungkanuparph
Keyword(s):  
Central Nervous System ◽  
Randomized Controlled Trial ◽  
Nervous System ◽  
Adverse Effects ◽  
Viral Suppression ◽  
Controlled Trial ◽  
Virological Suppression ◽  
Randomized Controlled ◽  
Resource Limited ◽  
Limited Setting

AbstractA randomized controlled noninferiority trial was conducted in HIV-infected patients receiving tenofovir/emtricitabine/efavirenz (TDF/FTC/EFV) with virological suppression in a resource-limited setting. Switching to TDF/FTC/rilpivirine was noninferior to continuing TDF/FTC/EFV in terms of maintaining compete viral suppression at 24 weeks and provided better lipid profiles and fewer central nervous system adverse effects.

Review of the Use of High-Dose Gadoteridol in the Magnetic Resonance Evaluation of Central Nervous System Tumors

1992 ◽  
Vol 27 (Supplement 1) ◽  
pp. S45 ◽  
Author(s):  
WILLIAM T.C. YUH ◽  
DAVID J. FISHER ◽  
NINA A. MAYR-YUH ◽  
E. TURGUT TALI ◽  
HOANG D. NGUYEN ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Magnetic Resonance ◽  
Central Nervous System Tumors ◽  
High Dose ◽  
Nervous System Tumors
Sign in / Sign up

Export Citation Format

Share Document